It was published on Jan. 6 in JAMA Internal Medicine. DoxyPEP is a new strategy for preventing STIs that involves taking a dose of doxycycline, a common and well-tolerated antibiotic medication, ...

Both studies in JAMA Internal Medicine supported the rising profile of doxyPEP as a way to counter the epidemic of syphilis, gonorrhea, and chlamydia infections, even if the data ...

The early rollout of doxyPEP — a dose of the antibiotic doxycycline after sex — has contributed to a decline in sexually ...

A new study tracked thousands of gay men taking PrEP and DoxyPEP.  A new study tracked thousands of gay men taking PrEP and ...

While the use of PrEP has helped drop the rates of HIV infections, instances of syphilis and chlamydia among queer men have ...

This is one of the first real-world studies to show the effectiveness of the tactic called doxyPEP, for doxycycline post-exposure prophylaxis, researchers said. Related 20% of people aged 15 to 49 ...

A new study in JAMA Internal Medicine led by the Harvard Pilgrim Health Care Institute examined whether doxycycline post-exposure prophylaxis (doxyPEP) was associated with declines in bacterial ...

Quarterly syphilis rates decreased from 1.7% prior to doxyPEP availability to 0.3% afterward, while quarterly chlamydia rates ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

It was published on January 6 in JAMA Internal Medicine. DoxyPEP is a new strategy for preventing STIs that involves taking a dose of doxycycline, a common and well-tolerated antibiotic medication ...

Opens in a new tab or window A decrease in California's sexually transmitted infections (STIs) followed early real-world adoption of doxycycline post-exposure prophylaxis (doxyPEP), suggesting ...